Hsu J, Prince H M, Imrie K R
University of Toronto Autologous Blood and Marrow Transplant Program, Toronto Hospital, Ontario, Canada.
Pharmacotherapy. 1996 Jul-Aug;16(4):652-5.
To determine whether prolonged ciprofloxacin administration following autologous bone marrow transplantation (ABMT) accelerates neutrophil recovery.
Retrospective analysis of 40 consecutive patients undergoing ABMT.
Tertiary care bone marrow transplant program.
Two sequential arms of 20 consecutive patients with Hodgkin's disease or non-Hodgkin's lymphoma undergoing ABMT.
The first arm received ciprofloxacin from the day of transplantation until initiation of broad-spectrum antibiotic therapy (median 5 days) while the second arm continued ciprofloxacin until recovery of the neutrophil count (median 15 days).
Neutrophil recovery was similar in the two groups (16 vs 14 days; p = 0.41). There were no differences in platelet recovery, bacteremia, or treatment-related mortality.
Prolonged ciprofloxacin administration does not significantly accelerate neutrophil recovery following ABMT.
确定自体骨髓移植(ABMT)后延长环丙沙星用药时间是否能加速中性粒细胞恢复。
对40例连续接受ABMT的患者进行回顾性分析。
三级医疗骨髓移植项目。
连续两组,每组20例接受ABMT的霍奇金病或非霍奇金淋巴瘤患者。
第一组从移植当天开始接受环丙沙星治疗,直至开始使用广谱抗生素治疗(中位时间5天),而第二组持续使用环丙沙星直至中性粒细胞计数恢复(中位时间15天)。
两组中性粒细胞恢复情况相似(16天对14天;p = 0.41)。血小板恢复、菌血症或治疗相关死亡率无差异。
ABMT后延长环丙沙星用药时间并不能显著加速中性粒细胞恢复。